The Global Betadex Sulfobutyl Ether Sodium Market was valued at USD 52.39 Million in 2025 and is projected to reach USD 84.70 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period (2025–2032). This robust growth is being driven by rising demand for advanced drug solubilization technologies, the expanding biopharmaceutical pipeline, and the growing need for high-purity pharmaceutical excipients in injectable and parenteral drug formulations across global markets.

As the pharmaceutical industry accelerates its focus on improving the bioavailability of poorly water-soluble drugs and developing next-generation injectable therapies, the spotlight is on the key manufacturers who are driving innovation, quality, and supply security. In this blog, we profile the Top 10 Companies in the Betadex Sulfobutyl Ether Sodium Industry—a mix of specialty chemical producers, pharmaceutical giants, and cyclodextrin technology pioneers shaping the future of global drug formulation.

---

🔹 1. Ligand Pharmaceuticals Incorporated

Headquarters: San Diego, California, USA
Key Offering: Captisol® (Sulfobutyl Ether Beta-Cyclodextrin, SBE-β-CD), pharmaceutical-grade excipient

Ligand Pharmaceuticals is the global pioneer and market leader in Betadex Sulfobutyl Ether Sodium technology, commercialized under its proprietary Captisol® brand. Captisol is one of the most extensively studied and widely used cyclodextrin derivatives in the pharmaceutical industry, with regulatory acceptance across the United States, Europe, and Asia. The compound has enabled the commercialization of numerous FDA-approved drugs by dramatically improving their solubility and stability profiles, particularly in injectable formulations used in oncology and critical care settings.

Key Strengths:

• Proprietary Captisol® technology with extensive regulatory dossiers and global approvals

• Strong licensing partnerships with leading global pharmaceutical companies

• Captisol is a key ingredient in multiple FDA-approved commercial products

Download FREE Sample Report:
Betadex Sulfobutyl Ether Sodium Market – View in Detailed Research Report

---

&#57#9️⃣ 2. Pfizer Inc.

Headquarters: New York, New York, USA
Key Offering: SBE-β-CD-based injectable formulations, pharmaceutical-grade excipients

Pfizer is one of the world’s largest pharmaceutical companies and a significant consumer and formulator of Betadex Sulfobutyl Ether Sodium in its commercial drug portfolio. The company leverages SBE-β-CD extensively in its parenteral drug development programs, utilizing the excipient to enhance the delivery of complex, poorly soluble molecules across therapeutic areas including oncology, infectious diseases, and antifungal treatments.

Key Strengths:

• Extensive in-house formulation expertise integrating SBE-β-CD into commercial products

• Global manufacturing infrastructure supporting large-scale injectable drug production

• Strong regulatory track record with SBE-β-CD-enabled formulations across multiple markets

---

&#57#8️⃣ 3. Merck KGaA (Sigma-Aldrich)

Headquarters: Darmstadt, Germany
Key Offering: Betadex Sulfobutyl Ether Sodium (research and pharmaceutical grade), cyclodextrin derivatives

Merck KGaA, through its life science division operating under the Sigma-Aldrich brand, is a leading global supplier of Betadex Sulfobutyl Ether Sodium for both research and pharmaceutical applications. The company offers SBE-β-CD with high purity specifications suitable for use in drug development, formulation studies, and commercial manufacturing. Its extensive global distribution network ensures reliable supply to pharmaceutical companies and academic research institutions worldwide.

Key Strengths:

• Comprehensive product portfolio spanning research-grade and pharmaceutical-grade SBE-β-CD

• Global supply chain reliability backed by Merck’s extensive logistics infrastructure

• Strong technical support capabilities for formulation development clients

Download FREE Sample Report:
Betadex Sulfobutyl Ether Sodium Market – View in Detailed Research Report

---

&#57#7️⃣ 4. Cyclolab Ltd.

Headquarters: Budapest, Hungary
Key Offering: SBE-β-CD (pharmaceutical grade), custom cyclodextrin derivatives, analytical services

Cyclolab is a specialized European manufacturer and research organization dedicated entirely to cyclodextrin chemistry. The company is recognized globally for its high-quality Betadex Sulfobutyl Ether Sodium products and deep scientific expertise in cyclodextrin inclusion complex formation. Cyclolab serves pharmaceutical companies across Europe, North America, and Asia, offering both standard and custom-synthesized cyclodextrin derivatives tailored to specific formulation requirements.

Key Strengths:

• Focused cyclodextrin expertise with decades of scientific research and development experience

• Capability to produce custom SBE-β-CD derivatives with specific degrees of substitution

• Comprehensive analytical and characterization services supporting drug development

---

&#57#6️⃣ 5. GLAND PHARMA LIMITED

Headquarters: Hyderabad, India
Key Offering: SBE-β-CD-enabled injectable formulations, parenteral drug products

Gland Pharma is one of India’s leading injectable-focused pharmaceutical companies and a significant player in the Betadex Sulfobutyl Ether Sodium market as both a formulator and supplier. The company operates state-of-the-art manufacturing facilities that are approved by the US FDA, EMA, and other major regulatory authorities, enabling it to produce high-quality SBE-β-CD-based injectable products for global markets. Its strong focus on complex injectables positions it strategically within this specialized excipient segment.

Key Strengths:

• US FDA and EMA-approved injectable manufacturing facilities

• Extensive experience in formulating complex parenteral drugs utilizing SBE-β-CD

• Growing export presence across North America, Europe, and Asia-Pacific markets

---

&#57#5️⃣ 6. Biophore India Pharmaceuticals Pvt. Ltd.

Headquarters: Hyderabad, India
Key Offering: Betadex Sulfobutyl Ether Sodium (pharmaceutical grade), API intermediates

Biophore India Pharmaceuticals is an emerging and increasingly prominent manufacturer of Betadex Sulfobutyl Ether Sodium, supplying pharmaceutical-grade material to drug companies in India and internationally. The company has invested significantly in its manufacturing capabilities and quality systems to meet the stringent requirements of regulated markets. Biophore is recognized for its competitive pricing and ability to offer reliable supply of high-purity SBE-β-CD, making it an important player in the growing Asian supply base for this critical excipient.

Key Strengths:

• Pharmaceutical-grade SBE-β-CD production meeting international quality standards

• Competitive cost structure supporting generic drug manufacturers in price-sensitive markets

• Expanding export capabilities to regulated markets in Europe and North America

---

&#57#4️⃣ 7. Pharmonix Biologicals Pvt. Ltd.

Headquarters: Mumbai, India
Key Offering: SBE-β-CD, cyclodextrin-based pharmaceutical excipients

Pharmonix Biologicals is a specialized Indian pharmaceutical excipient manufacturer with a focused presence in the Betadex Sulfobutyl Ether Sodium market. The company caters primarily to domestic pharmaceutical manufacturers while steadily building its capabilities to serve international clients. Pharmonix has established itself as a reliable source of cyclodextrin derivatives for formulation scientists working on solubility enhancement and parenteral drug development projects, particularly within the rapidly growing Indian pharmaceutical sector.

Key Strengths:

• Specialized focus on pharmaceutical excipients including SBE-β-CD and related cyclodextrin derivatives

• Strong customer relationships within India’s thriving generic pharmaceutical industry

• Growing technical expertise in cyclodextrin inclusion complex characterization and formulation support

Download FREE Sample Report:
Betadex Sulfobutyl Ether Sodium Market – View in Detailed Research Report

---

&#57#3️⃣ 8. Zhiyuan Bio-Tech Co., Ltd.

Headquarters: Zibo, Shandong, China
Key Offering: Betadex Sulfobutyl Ether Sodium, native cyclodextrins, modified cyclodextrin derivatives

Zhiyuan Bio-Tech is one of China’s leading manufacturers of cyclodextrin products, including Betadex Sulfobutyl Ether Sodium. The company benefits from China’s strong position in cyclodextrin raw material production, as the country is among the world’s largest producers of native beta-cyclodextrin derived from corn starch. Zhiyuan has positioned itself as a cost-competitive supplier of SBE-β-CD for both domestic Chinese pharmaceutical manufacturers and international clients, contributing significantly to the Asia-Pacific region’s growing share of the global market.

Key Strengths:

• Vertically integrated production from native cyclodextrin through to modified derivatives

• Cost-competitive manufacturing supported by China’s abundant agricultural raw material base

• Expanding production capacity to meet rising domestic and international demand

---

&#57#2️⃣ 9. Ashland Global Holdings Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Pharmaceutical excipients, specialty chemical ingredients for drug formulation

Ashland Global Holdings is a specialty chemicals company with a significant presence in the pharmaceutical excipients market. While the company offers a broad portfolio of formulation ingredients, its expertise in solubility enhancement technologies and its established relationships with pharmaceutical manufacturers worldwide make it a relevant and growing participant in the Betadex Sulfobutyl Ether Sodium ecosystem. Ashland’s technical application expertise and global reach support pharmaceutical formulators seeking advanced excipient solutions for complex drug delivery challenges.

Key Strengths:

• Broad pharmaceutical excipient portfolio with deep formulation application expertise

• Global commercial presence serving pharmaceutical customers across all major markets

• Strong investment in technical service capabilities to support drug development partnerships

---

&#57#1️⃣ 10. Roquette Frères

Headquarters: Lestrem, France
Key Offering: Pharmaceutical excipients, starch-derived specialty ingredients, cyclodextrin-related products

Roquette Frères is a global leader in plant-based ingredients and pharmaceutical excipients, with a strong foundation in starch chemistry that underpins cyclodextrin production. The company’s expertise in converting agricultural raw materials into high-value pharmaceutical-grade specialty ingredients positions it as an important participant in the broader Betadex Sulfobutyl Ether Sodium value chain. Roquette’s commitment to sustainable and green chemistry manufacturing practices, combined with its extensive global reach, makes it a trusted partner for pharmaceutical companies seeking reliable excipient supply.

Key Strengths:

• Deep expertise in starch-based chemistry providing a natural foundation for cyclodextrin-related products

• Global manufacturing network with facilities in Europe, Asia, and the Americas

• Strong commitment to sustainable manufacturing practices aligned with pharmaceutical industry ESG goals

Get Full Report Here:
Betadex Sulfobutyl Ether Sodium Market – View in Detailed Research Report

---

🌎 Outlook: The Future of Betadex Sulfobutyl Ether Sodium Is Innovation-Driven and Expanding

The Betadex Sulfobutyl Ether Sodium market is undergoing a significant transformation. While its established role in solubility enhancement for conventional small-molecule drugs remains the cornerstone of demand, the industry is witnessing accelerating investment in next-generation applications, advanced manufacturing technologies, and expanding geographic markets. The compound’s versatility as a pharmaceutical excipient, combined with its strong regulatory acceptance and proven safety profile, positions it well for sustained growth throughout the forecast period and beyond.

📈 Key Trends Shaping the Market:

• Rapid expansion of the global injectable drugs market driving sustained SBE-β-CD demand

• Growing exploration of SBE-β-CD in biologics, gene therapies, and vaccine stabilization

• Increasing biosimilar development creating parallel demand for advanced pharmaceutical excipients

• Asia-Pacific manufacturers scaling production capacity to reduce global supply chain concentration risk

• Investment in green chemistry and more efficient synthesis processes to reduce production costs

• Patent expirations of blockbuster SBE-β-CD-containing drugs opening significant generic market opportunities

Get Full Report Here:
Betadex Sulfobutyl Ether Sodium Market – View in Detailed Research Report

The companies profiled above are not only supplying a critical pharmaceutical ingredient—they’re enabling the next generation of life-saving drug therapies by solving one of the pharmaceutical industry’s most persistent formulation challenges. As the market continues to evolve, those players investing in technological innovation, regulatory compliance, and global supply chain resilience will be best positioned to lead this dynamic and growing sector.